|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/27/23 Advanced Oxygen Technologies Inc. 10-Q 9/30/23 46:2.5M Discount Edgar/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 457K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 14K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 14K
11: R1 Cover HTML 68K
12: R2 Condensed Consolidated Balance Sheets HTML 112K
13: R3 Condensed Consolidated Balance Sheets HTML 40K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 92K
and Comprehensive Income (Loss) (Unaudited)
15: R5 Condensed Consolidated Statements of Stockholders HTML 40K
Equity (Unaudited)
16: R6 Condensed Consolidated Statements of Cash Flows HTML 63K
(Unaudited)
17: R7 Organization and Line of Business HTML 22K
18: R8 Summary of Significant Accounting Policies HTML 37K
19: R9 Revenue HTML 30K
20: R10 Property and Equipment HTML 20K
21: R11 Related Party Transactions HTML 20K
22: R12 Notes Payable HTML 26K
23: R13 Stockholders Equity HTML 25K
24: R14 Segment and Geographic Information HTML 66K
25: R15 Subsequent Events HTML 16K
26: R16 Summary of Significant Accounting Policies HTML 65K
(Policies)
27: R17 Revenue (Tables) HTML 27K
28: R18 Property Equipment (Tables) HTML 19K
29: R19 Notes Payable (Tables) HTML 19K
30: R20 Segment and Geographic Information (Tables) HTML 61K
31: R21 Summary of Significant Accounting Policies HTML 19K
(Details Narrative)
32: R22 Revenue (Details) HTML 34K
33: R23 Property and Equipment (Details) HTML 17K
34: R24 Property and Equipment (Details narrative) HTML 16K
35: R25 Related Party Transactions (Details Narrative) HTML 18K
36: R26 Notes Payable (Details) HTML 26K
37: R27 Notes Payable (Details Narrative) HTML 39K
38: R28 Stockholders Equity (Details Narrative) HTML 47K
39: R29 Segment and Geographic Information (Details) HTML 35K
40: R30 Segment and Geographic Information (Details 1) HTML 23K
41: R31 Segment and Geographic Information (Details 2) HTML 42K
44: XML IDEA XML File -- Filing Summary XML 73K
42: XML XBRL Instance -- aoxy_10q_htm XML 521K
43: EXCEL IDEA Workbook of Financial Report Info XLSX 65K
8: EX-101.CAL XBRL Calculations -- aoxy-20230930_cal XML 86K
10: EX-101.DEF XBRL Definitions -- aoxy-20230930_def XML 207K
7: EX-101.LAB XBRL Labels -- aoxy-20230930_lab XML 405K
9: EX-101.PRE XBRL Presentations -- aoxy-20230930_pre XML 336K
6: EX-101.SCH XBRL Schema -- aoxy-20230930 XSD 80K
45: JSON XBRL Instance as JSON Data -- MetaLinks 237± 330K
46: ZIP XBRL Zipped Folder -- 0001477932-23-007920-xbrl Zip 99K
EXHIBIT 31.2
CERTIFICATIONS
I, Robert Wolfe, certify that:
| 1. | I have reviewed this Quarterly Report on Form 10-Q for the 3 month period ended September 30, 2023 of Advanced Oxygen Technologies, Inc.; |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for, the periods presented in this report; |
|
|
|
| 4. | I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
| (a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
|
| (b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
|
| (c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| (d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
| (a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| (b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: October 27, 2023 | By: | /s/ Robert Wolfe | |
|
|
|
| |
|
|
| Chief Financial Officer |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/27/23 | None on these Dates | ||
| For Period end: | 9/30/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/28/22 Advanced Oxygen Technologies Inc. 10-K 6/30/22 55:8.2M Discount Edgar/FA 12/09/14 Advanced Oxygen Technologies Inc. 8-K:5,8,9 12/05/14 2:22K Discount Edgar/FA |